A manuscript on E2F1 and lncRNA SLC16A1-AS1 in press in Theranostics

Long non-coding RNAs (lncRNAs) have emerged as integral components of E2F1-regulated gene regulatory networks (GRNs), but their implication in advanced or treatment-refractory malignancy is unknown. Our results unveil a new gene regulatory program by which E2F1-induced lncRNA-SLC16A1-AS1 forms a complex with its transcription factor that promotes cancer metabolic reprogramming towards the acquisition of a hybrid oxidative phosphorylation/glycolysis cell phenotype favoring bladder cancer invasiveness.​

 

Previous Post
Health research: Land promotes further alliances
Next Post
Notable accomplishment
Menu